Provider-Based HPV Vaccine Promotion Interventions: A Meta-analysis

Area of Science:

• Public Health
• Vaccinology
• Health Services Research

Background:

• Provider-based interventions are widely used to promote human papillomavirus (HPV) vaccination, but their effectiveness requires further clarification.
• Assessing the impact and cost-effectiveness of these interventions is crucial for optimizing public health strategies.
• This review synthesizes evidence on provider-based approaches to enhance HPV vaccine uptake.

Approach:

• A systematic review and meta-analysis were conducted, searching major databases (PubMed, Medline, Embase, Cochrane Library) for relevant studies published between 2007 and 2021.
• Data extraction focused on intervention effects (initiation, completion, next dose rates) and costs.
• Meta-analysis pooled effect sizes to quantify the impact of provider-based interventions on HPV vaccination coverage.

Key Points:

• 32 studies of provider-based interventions were analyzed, including strategies like provider training, reminders, and feedback.
• Meta-analysis revealed significant improvements: a 3.7% increase in HPV vaccine initiation and a 9.4% increase in patients receiving the next needed dose.
• High heterogeneity across studies was noted, necessitating the use of random-effects modeling.

Conclusions:

• Provider-based interventions demonstrate effectiveness in improving human papillomavirus (HPV) vaccination rates.
• Sustained and continuous implementation of these interventions are critical factors for achieving and maintaining success.
• Further research is needed to compare different provider-based approaches and address study heterogeneity.